Global Financial Private Client LLC Boosts Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Global Financial Private Client LLC grew its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 8.5% during the fourth quarter, Holdings Channel.com reports. The fund owned 9,326 shares of the exchange traded fund’s stock after purchasing an additional 727 shares during the quarter. Global Financial Private Client LLC’s holdings in SPDR S&P Biotech ETF were worth $840,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the stock. Hartline Investment Corp boosted its holdings in shares of SPDR S&P Biotech ETF by 2.0% in the third quarter. Hartline Investment Corp now owns 5,502 shares of the exchange traded fund’s stock valued at $544,000 after purchasing an additional 106 shares during the period. Signature Estate & Investment Advisors LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 5.7% in the 3rd quarter. Signature Estate & Investment Advisors LLC now owns 2,336 shares of the exchange traded fund’s stock worth $231,000 after buying an additional 125 shares during the period. Denver Wealth Management Inc. lifted its holdings in shares of SPDR S&P Biotech ETF by 0.9% in the 3rd quarter. Denver Wealth Management Inc. now owns 14,779 shares of the exchange traded fund’s stock worth $1,460,000 after buying an additional 127 shares during the period. Resources Management Corp CT ADV grew its position in shares of SPDR S&P Biotech ETF by 30.3% during the 2nd quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock worth $55,000 after buying an additional 138 shares in the last quarter. Finally, Trust Co. of Vermont increased its stake in shares of SPDR S&P Biotech ETF by 4.7% during the third quarter. Trust Co. of Vermont now owns 3,058 shares of the exchange traded fund’s stock valued at $302,000 after buying an additional 138 shares during the period.

SPDR S&P Biotech ETF Price Performance

NYSEARCA:XBI opened at $89.13 on Tuesday. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47. The company has a 50-day moving average of $95.28 and a 200 day moving average of $97.10. The firm has a market cap of $6.79 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.